65,437 trials
Major Depressive Disorder
Primary: Change From Baseline in Behavior Rating Inventory of Executive Function - Adult Version Global Executive Composite T-score (BRIEF-A GEC T) at Week 9, Last Observation…
Osteoporosis
Primary: Berg Balance Scale (BBS) — 50.68; 43.13 scores on a scale
Wrinkles
Primary: Severity of the Forehead Wrinkles by the Evaluator at Maximum Contraction and at Rest Using the Forehead Wrinkles Severity Scale (0 to 3) at Each Study Visit and for…
Thoracic Aortic Aneurysm
Primary: Percentage of Participants That Did NOT Experience Aneurysm-Related Mortality (Post-market Primary Endpoint) — 94.8 Percentage of participants
Coronary Artery Disease
Primary: Maximum Observed Everolimus Blood Concentration (Cmax) — 0.71; 0.67; 0.91 ng/mL
Opioid-Related Disorders · Opiate Dependence · Drug Abuse
Primary: Retention Rate After 12 Months of Treatment With Suboxone — 59.9 % of participants
Acne Vulgaris
Primary: Percent Change From Baseline in Total Lesion Count — -74.1; -56.8 percent of change
Liver Disease · Liver Transplantation
Primary: Proportion of Participants Who Have Graft Loss or Death — 0.22 Proportion of Participants
Diabetic Foot Ulcer
Primary: Number of Participants Without Adverse Events — 8; 7 participants
Epithelial Ovarian Cancer · Primary Peritoneal Carcinoma
Primary: 6-month Progression-Free Rate — 62.5 percentage of patients
Gastroesophageal Reflux
Primary: Time to Reach the Peak Plasma Concentration (Tmax) — 4.4; 4.1; 4.1 hours — p=0.809
Influenza
Primary: The Geometric Mean (GM) Number of Influenza-specific CD4 T-cells Per Million CD4+ T-cells Identified After in Vitro Stimulation With Pooled Vaccine Strains Which Are…
Restless Legs Syndrome
Primary: Change in International Restless Legs Syndrome Study Group (IRLSSG) Severity Scale. — -10.4; -7.6; -10.8; -6.0 points on a scale
Influenza
Primary: Number of Subjects Reporting Any and Grade 3 Solicited Local Adverse Events (AEs) — 1; 0; 0; 0 Participants
Cardiovascular · Dyslipidemia
Primary: Number of Participants With Post-index Cardiovascular (CV) Events — 700; 1012 Participants — p=<0.001